DEVELOPMENT OF SINGLE DOMAIN ANTIBODY (SDAB) BASED THERAPEUTICS TARGETING SARS-COV-2 SPIKE PROTEIN FOR THE TREATMENT OF COVID-19
$120,137FY2021Defense Health AgencyDOD
Inhibrx, Inc., La Jolla CA
Investigators
View source on USAspending →DEVELOPMENT OF SINGLE DOMAIN ANTIBODY (SDAB) BASED THERAPEUTICS TARGETING SARS-COV-2 SPIKE PROTEIN FOR THE TREATMENT OF COVID-19 · GrantIndex